NDAORALCAPSULE
Approved
May 2020
Lifecycle
Peak
Competitive Pressure
0/100
Mechanism of Action
estradiol/norethindrone acetate (E2/NETA), a combination of estrogen and progestin. Elagolix is a GnRH receptor antagonist that inhibits endogenous GnRH signaling by binding competitively to GnRH receptors in the pituitary gland. Administration of elagolix results in dose-dependent suppression of…
Loss of Exclusivity
LOE Date
Aug 27, 2040
176 months away
Patent Expiry
Aug 27, 2040